🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

US STOCKS-Wall Street advances as earnings season hits the road running

Published 15/10/2019, 19:26
© Reuters.  US STOCKS-Wall Street advances as earnings season hits the road running
US500
-
DJI
-
AAPL
-
IXIC
-
SPSY
-
SPXHC
-
SPLRCL
-
ROKU
-

(For a live blog on the U.S. stock market, click LIVE/ or type

LIVE/ in a news window.)

* JPMorgan hits record high on earnings beat

* UnitedHealth, Johnson & Johnson shares jump after results

* Brexit hopes boost sentiment

* Indexes up: Dow 1.09%, S&P 1.20%, Nasdaq 1.43%

(Updates to late afternoon, changes dateline, byline)

By Stephen Culp

NEW YORK, Oct 15 (Reuters) - Wall Street jumped on Tuesday

as third-quarter reporting season kicked into high gear with a

spate of upbeat earnings reports that brought buyers back to the

equities market.

All three major U.S. stock indexes touched three-week highs,

gaining more than 1% in a broad-based rally.

"It's all going to be about earnings for the next couple of

weeks and that's a good thing," said Oliver Pursche, chief

market strategist at Bruderman Asset Management in New York.

"These early beats are a very positive sign."

Even so, Pursche warned that global headwinds persist.

"We're likely to see corporate earnings and monetary policy

helping to lift stocks, while geopolitical events will put

pressure on stocks," Pursche said. "As such, we'll probably be

in this trading range for some time."

On the geopolitical front, investors welcomed news that

Britain and the European Union could reach a deal in time for a

leaders' summit this week. Major financial firms JPMorgan Chase & Co JPM.N , Citigroup

Inc C.N , Goldman Sachs Group Inc GS.N and Wells Fargo & Co

WFC.N all posted results, as did healthcare giants Johnson &

Johnson JNJ.N and UnitedHealth Group Inc UNH.N .

Among the big banks, JPMorgan Chase stock hit a record high

after it handily beat estimates on bond trading and underwriting

strength. Its shares were last up 3.6%.

Citigroup rose 2.0% following its profit beat. Wells Fargo results were less upbeat, as its profit slid 26%

due to sinking mortgage income and legal costs. Goldman Sachs'

profit miss was attributed to weak underwriting. Wells Fargo

rose 2.8%, while Goldman gained 1.0%. Prescription drug sales helped drive Johnson & Johnson's

upside surprise, while UnitedHealth raised its 2019 guidance on

pharmacy benefit growth. Their shares were up 1.9% and 8.2%,

respectively.

Analysts currently expect S&P 500 third-quarter earnings to

have contracted by 3% from last year, down from the 12.1% growth

seen a year ago, according to Refinitiv data.

Of the 34 S&P 500 companies that have reported so far, 88.2%

have come in above consensus estimates.

The Dow Jones Industrial Average .DJI rose 292.98 points,

or 1.09%, to 27,080.34, the S&P 500 .SPX gained 35.49 points,

or 1.20%, to 3,001.64 and the Nasdaq Composite .IXIC added

114.98 points, or 1.43%, to 8,163.63.

Among the 11 major sectors in the S&P 500, eight were in the

black, with healthcare .SPXHC , communications services

.SPLRCL and financials .SPSY enjoying the largest percentage

gains.

Blackrock Inc BLK.N , the world's largest asset manager,

beat analyst estimates on strong inflows into its fixed income

and cash management business, sending its stock up 2.7%.

In other news, shares of Roku Inc ROKU.O surged 10.8%

after the announcing Apple Inc's AAPL.O TV app was available

on its platform and Apple TV+ would be available after it was

launched. Bank of America BAC.N , expected to post results on

Wednesday, rose 2.8% after a Bloomberg report that Warren

Buffett' Berkshire Hathaway was seeking permission from the

Federal Reserve to boost his stake in the bank above 10%.

Advancing issues outnumbered declining ones on the NYSE by a

2.28-to-1 ratio; on Nasdaq, a 2.92-to-1 ratio favored advancers.

The S&P 500 posted 16 new 52-week highs and no new lows; the

Nasdaq Composite recorded 36 new highs and 62 new lows.

S&P 500 earnings vs price performance https://tmsnrt.rs/35CNLAo

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.